This is surely the kind of deal Phylogica would like to make
http://www.boston.com/business/ticker/2008/12/archemix_forms.html
Archemix Corp. has formed an alliance with GlaxoSmithKline plc, the British drug maker, that will yield Archemix an up-front payment of $27.5 million.
Archemix's area of concentration is the development of aptamers as a new class of directed therapeutics for the prevention and treatment of chronic and acute diseases.
Just replace "aptamer" with "phylomer".
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
-0.025(1.89%) |
Mkt cap ! $755.3M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.32 | $1.30 | $478.1K | 365.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |